Anika Therapeutics, Inc. Operating Lease Liability
Anika Therapeutics, Inc. (ANIK) had Operating Lease Liability of $26.25 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-03
- 2025-12-31: Operating Lease, Liability $26.25M.
- 2024-12-31: Operating Lease, Liability $25.93M.
- 2019-09-30: Operating Lease, Liability $22.71M.
- 2019-06-30: Operating Lease, Liability $23.07M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $26.25M 10-K · filed 2026-03-03 |
| 2024-12-31 | $25.93M 10-K · filed 2025-03-17 |
| 2019-09-30 | $22.71M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $23.07M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $23.31M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |